These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 24124831)

  • 1. JAAD Grand Rounds quiz: a 42-year-old woman with stage IIIC melanoma treated with ipilimumab.
    Beute TC
    J Am Acad Dermatol; 2013 Nov; 69(5):845-847. PubMed ID: 24124831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. JAAD grand rounds. JAAD grand rounds quiz: a 64-year-old woman with an annular rash on the arm.
    Micheletti R; Gluckman S
    J Am Acad Dermatol; 2015 Feb; 72(2):371-2. PubMed ID: 25592357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. JAAD Grand Rounds quiz: A subcutaneous nodule on the right shoulder.
    Hung CT; Wang WM
    J Am Acad Dermatol; 2015 Nov; 73(5):889-91. PubMed ID: 26475550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. JAAD Grand Rounds quiz. Asymptomatic necrotic ulcer on leg.
    Burdick LM; Hamrock D; Mawhorter S; Tuthill R; Karai L
    J Am Acad Dermatol; 2009 Jul; 61(1):172-4. PubMed ID: 19539869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. JAAD Grand Rounds quiz. Linear and whorled hyperkeratosis in a newborn.
    Donaldson MR; Camp T; Wells MJ
    J Am Acad Dermatol; 2009 Sep; 61(3):542-4. PubMed ID: 19700028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant ipilimumab in stage III melanoma: New landscape, new questions.
    Eggermont AM
    Eur J Cancer; 2016 Dec; 69():39-42. PubMed ID: 27816830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ipilimumab in melanoma.
    Specenier P
    Expert Rev Anticancer Ther; 2016 Aug; 16(8):811-26. PubMed ID: 27403706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic review: surgery for patients with metastatic melanoma during active treatment with ipilimumab.
    Baker JJ; Stitzenberg KB; Collichio FA; Meyers MO; Ollila DW
    Am Surg; 2014 Aug; 80(8):805-10. PubMed ID: 25105403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complete regression of a previously untreated melanoma brain metastasis with ipilimumab.
    Schartz NE; Farges C; Madelaine I; Bruzzoni H; Calvo F; Hoos A; Lebbé C
    Melanoma Res; 2010 Jun; 20(3):247-50. PubMed ID: 20216240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Metastatic melanoma: some hope from ipilimumab and vemurafenib].
    Piérard-Franchimont C; Piérard GE
    Rev Med Liege; 2012 Feb; 67(2):64-8. PubMed ID: 22482234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. JAAD grand rounds quiz*: Dusky intertriginous plaques and acral erythema after bone marrow transplant.
    Lane N; Donaldson MR; Stetson CL; Smith JL
    J Am Acad Dermatol; 2010 Jul; 63(1):175-7. PubMed ID: 20542188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ipilimumab treatment of metastatic melanoma].
    Ghasemi H; Schmidt H; Stolle LB
    Ugeskr Laeger; 2015 Jan; 177(2A):108-9. PubMed ID: 25612993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The best treatments to use after checkpoint inhibition in melanoma.
    McArthur G
    Clin Adv Hematol Oncol; 2017 Apr; 15(4):242-245. PubMed ID: 28591097
    [No Abstract]   [Full Text] [Related]  

  • 14. An immune-active tumor microenvironment favors clinical response to ipilimumab.
    Ji RR; Chasalow SD; Wang L; Hamid O; Schmidt H; Cogswell J; Alaparthy S; Berman D; Jure-Kunkel M; Siemers NO; Jackson JR; Shahabi V
    Cancer Immunol Immunother; 2012 Jul; 61(7):1019-31. PubMed ID: 22146893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral CD8 effector-memory type 1 T-cells correlate with outcome in ipilimumab-treated stage IV melanoma patients.
    Wistuba-Hamprecht K; Martens A; Heubach F; Romano E; Geukes Foppen M; Yuan J; Postow M; Wong P; Mallardo D; Schilling B; Di Giacomo AM; Khammari A; Dreno B; Maio M; Schadendorf D; Ascierto PA; Wolchok JD; Blank CU; Garbe C; Pawelec G; Weide B
    Eur J Cancer; 2017 Mar; 73():61-70. PubMed ID: 28167454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphomics predicts response to ipilimumab in patients with stage IV melanoma.
    Sabel MS; Lee J; Wang A; Lao C; Holcombe S; Wang S
    J Surg Oncol; 2015 Sep; 112(4):333-7. PubMed ID: 26251199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enterocolitis in a patient being treated with ipilimumab for metastatic melanoma.
    Koch C; Paetzold S; Trojan J
    Gastroenterology; 2012 Aug; 143(2):298, 504, 505. PubMed ID: 22709738
    [No Abstract]   [Full Text] [Related]  

  • 18. Ipilimumab in a patient with known Crohn's disease: to give or not to give?
    Gielisse EA; de Boer NK
    J Crohns Colitis; 2014 Dec; 8(12):1742. PubMed ID: 25154682
    [No Abstract]   [Full Text] [Related]  

  • 19. Radiologic aspects of immune-related tumor response criteria and patterns of immune-related adverse events in patients undergoing ipilimumab therapy.
    O'Regan KN; Jagannathan JP; Ramaiya N; Hodi FS
    AJR Am J Roentgenol; 2011 Aug; 197(2):W241-6. PubMed ID: 21785048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ipilimumab in treatment-naive and previously treated patients with metastatic melanoma: retrospective analysis of efficacy and safety data from a phase II trial.
    Thompson JA; Hamid O; Minor D; Amin A; Ron IG; Ridolfi R; Assi H; Berman D; Siegel J; Weber JS
    J Immunother; 2012 Jan; 35(1):73-7. PubMed ID: 22130164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.